Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2010
03/04/2010WO2009129491A3 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
03/04/2010WO2009129147A4 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
03/04/2010WO2009126835A3 Magnetic nanoparticle and method for imaging t cells
03/04/2010WO2009095057A3 Transdermal therapeutic system having urea components
03/04/2010WO2009081287A3 Polysaccharide nanoparticles
03/04/2010WO2009056703A8 Flavoured clay-based therapeutic composition
03/04/2010WO2009050692A3 Platelet-activating factor (paf) analogs and uses thereof
03/04/2010WO2009043049A3 Pharmaceutical formulations
03/04/2010WO2009030964A9 Amphiphilic oxalamide organogelators designed for gelation of organic solvents, water and hydrocarbon commercial fuels
03/04/2010WO2009026257A9 Methods and compositions for controlling the bioavailability of poorly soluble drugs
03/04/2010WO2009008951A3 Methods and systems for coating a microneedle with a dosage of a biologically active compound
03/04/2010WO2009007992A8 Pharmaceutical composition produced by microprecipitation
03/04/2010WO2008144084A3 Lotion composition for personal use
03/04/2010US20100056972 Adhesive patch
03/04/2010US20100056632 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
03/04/2010US20100056476 Pharmaceutical compositions comprising peranhydrocyclodextrin
03/04/2010US20100056436 Pharmaceutical Compositions Including Low Dosages of Desmopressin
03/04/2010US20100056425 Absorption enhancers such as E.G. BHT, BHA or propyl gallate
03/04/2010US20100055220 Skin external preparation in the form of water-in-oil emulsion comprising ceramide
03/04/2010US20100055202 Antiinfective free intramammary veterinary composition
03/04/2010US20100055195 Biodegradable bmp nanofiber and uses thereof
03/04/2010US20100055194 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
03/04/2010US20100055193 Stable powder formulation containing an anticholinergic agent
03/04/2010US20100055192 Micronized particles of low-dosage strength active agents for powder formulations for inhalation
03/04/2010US20100055191 Powder composition, method for producing the same, and food composition, cosmetic composition and pharmaceutical composition containing the same
03/04/2010US20100055190 Sterol-Containing Compositions
03/04/2010US20100055189 Nanoparticles for immunotherapy
03/04/2010US20100055188 Nano-valves for small-molecule drug delivery
03/04/2010US20100055187 Nanovitamin synthesis
03/04/2010US20100055186 Photocrosslinkable oligo(poly (ethylene glycol) fumarate) hydrogels for cell and drug delivery
03/04/2010US20100055185 Composition and method for treating hemorrhoids and/or anorectal disorders
03/04/2010US20100055184 Hydrogels for vocal cord and soft tissue augmentation and repair
03/04/2010US20100055183 Trimeprazine and ethopropazine derivatives for promoting bone growth
03/04/2010US20100055182 Use of guanidinoacetic acid (salts) combination with betaine and/or choline to produced an agent that is beneficial to health
03/04/2010US20100055181 Controlled release dosage forms of zolpidem
03/04/2010US20100055180 Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
03/04/2010US20100055179 Composition of and Method for Preparing Orally Disintegrating Tablets Containing a High Dose of Pharmaceutically Active Ingredients
03/04/2010US20100055178 Enteric-coated creatine compositions and methods of use thereof
03/04/2010US20100055177 Modified release composition of levetiracetam and process for the preparation thereof
03/04/2010US20100055176 Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia
03/04/2010US20100055175 Soft gelatin capsule shells containing oil soluble flavoring and methods of making the same
03/04/2010US20100055174 gelatin outer shell, plasticizer, starch, and antitacking agent
03/04/2010US20100055173 Release of statins in the intestine
03/04/2010US20100055172 Encapsulated soy extracts and process for preparing same
03/04/2010US20100055171 Pharmaceutical Formulation Comprising Donepezil
03/04/2010US20100055170 Metal core nanocapsules
03/04/2010US20100055169 Cationic lipids and uses thereof
03/04/2010US20100055168 Cationic lipids and uses thereof
03/04/2010US20100055167 Stem cell delivery of anti-neoplastic medicine
03/04/2010US20100055166 Novel method and compositions
03/04/2010US20100055165 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing
03/04/2010US20100055164 Synthetic lung surfactant and use thereof
03/04/2010US20100055163 Formulation of natural triterpenes and biophenols obtained from the genus olea in liposomes
03/04/2010US20100055162 Adhesive patch
03/04/2010US20100055161 Hydrogel face mask for delivering skin care agents
03/04/2010US20100055160 Analgesic anti-inflammatory patches for topical use
03/04/2010US20100055159 Percutaneous preparations
03/04/2010US20100055158 Environmentally Activated Compositions, Articles and Methods
03/04/2010US20100055156 Composition for the topical transmission of active ingredients into the human or animal body
03/04/2010US20100055154 Coaxial electrospun fibers and structures and methods of forming the same
03/04/2010US20100055153 Multipurpose hydrogel compositions and products
03/04/2010US20100055152 Antihistamine and antihistamine-like nasal application, products, and method
03/04/2010US20100055150 Method and composition for treatment of skeletal dysplasias
03/04/2010US20100055146 Cyclic angiotensin analogs
03/04/2010US20100055137 Microemulsion & sub-micron emulsion process & compositions
03/04/2010US20100055097 Stable lyophilized pharmaceutical formulation of igg antibodies
03/04/2010US20100055051 Malodour counteracting composition
03/04/2010US20100055050 Nicotine chewing gum on a stick
03/04/2010US20100055049 Insulin derivative formulations for pulmonary delivery
03/04/2010US20100055048 Acute treatment of headache with phenothiazine antipsychotics
03/04/2010US20100055047 Methods for treating bronchial premalignancy and lung cancer
03/04/2010US20100055046 Composition and method for treating colds
03/04/2010US20100055045 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
03/04/2010US20100055044 Ruthenium compounds and compositions
03/04/2010US20100055042 Enhancing Clot Busting Medication in Stroke with Directed Drug Convection using Magnetic Nano-Particles
03/04/2010US20100052900 System to monitor the ingestion of medicines
03/04/2010US20100051025 Attenuation of vasoactive oxygen carrier-induced vasoconstriction
03/04/2010DE102008045339A1 Pharmazeutisches Pellet Pharmaceutical pellet
03/04/2010DE102008044994A1 Elektronische Pille zur steuerbaren Abgabe einer Substanz, insbesondere eines Medikaments, in einem menschlichen oder tierischen Körper Electronic pill for controllably dispensing a substance, especially a drug in a human or animal body
03/04/2010CA2735698A1 Improvements relating to pharmaceutical compositions
03/04/2010CA2735581A1 Controlled-released peptide formulations
03/04/2010CA2735413A1 Microparticles
03/04/2010CA2735318A1 Nanoparticles for immunotherapy
03/04/2010CA2732780A1 Wet granulation system comprising at least one ultrasonic nozzle
03/03/2010EP2158920A1 Stabilizing alkylglycoside compositions and methods thereof
03/03/2010EP2158911A1 Stable pharmaceutical formulations of montelukast sodium
03/03/2010EP2158907A2 A composition for use as a medicament for topical application to skin
03/03/2010EP2158905A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158904A2 Composition for the Transdermal Delivery of Fentanyl
03/03/2010EP2158903A2 Transparent Transdermal Nicotine Delivery Devices
03/03/2010EP2158902A1 Ion binding compositions
03/03/2010EP2158901A2 Alpha aztreonam lysinate
03/03/2010EP2158900A1 Polymeric delivery formulations of leuprolide with improved efficacy
03/03/2010EP2158899A1 Improved composition for the topical transmission of active ingredients into the human or animal body
03/03/2010EP2158898A1 Stabilizing alkylglycoside compositions and method thereof
03/03/2010EP2158223A2 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same
03/03/2010EP2157970A1 Transdermal delivery devices assuring an improved release of an active principle through a biological interface
03/03/2010EP2157969A2 Method for preparing a granulated form
03/03/2010EP2157967A2 Suspension formulations of insulinotropic peptides and uses thereof
03/03/2010EP2157864A2 Stabilized picoplatin dosage form
1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 2991